Literature DB >> 27472432

Between GERD and NERD: the relevance of weakly acidic reflux.

Nicola de Bortoli1, Andrea Ottonello2, Frank Zerbib3, Daniel Sifrim4, C Prakash Gyawali5, Edoardo Savarino6.   

Abstract

Nonerosive reflux disease (NERD) is a common condition and the most frequent phenotype of gastroesophageal reflux disease (GERD). NERD is extremely heterogeneous and includes patients with negative endoscopy but abnormal esophageal acid exposure and/or positive reflux-symptom association analysis (hypersensitive esophagus). This segregation is only possible owing to the use of impedance-pH monitoring. Indeed, weakly acidic reflux represents one of the most common causes of refractory symptoms in patients evaluated off antisecretory therapy and, more importantly, during antisecretory drug treatment. Patients with heartburn who do not have any type of reflux underlying their symptoms (functional heartburn) must be excluded from the category of GERD. The drawbacks of impedance-pH are mainly due to the day-to-day variability of the test and the fact that the accuracy of the symptom-reflux correlation scores is often far from perfect. Some histopathological characteristics, such as dilated intercellular spaces, can be helpful in distinguishing patients with NERD through esophageal biopsies. Patients with NERD in whom acid is the main pathogenetic factor respond successfully to proton pump inhibitor therapy, while those with hypersensitive esophagus to weakly acidic reflux could be treated with reflux inhibitors or surgery, although further controlled studies are required.
© 2016 New York Academy of Sciences.

Entities:  

Keywords:  GERD; NERD; heartburn; multichannel impedance and pH monitoring; proton pump inhibitors; weakly acidic reflux

Mesh:

Substances:

Year:  2016        PMID: 27472432     DOI: 10.1111/nyas.13169

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease.

Authors:  Rishi D Naik; Lauren Evers; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

2.  Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial.

Authors:  Xia Li; Haomeng Wu; Beihua Zhang; Ting Chen; Xiaoshuang Shi; Jinxin Ma; Jiaqi Zhang; Xudong Tang; Fengyun Wang
Journal:  Trials       Date:  2022-10-18       Impact factor: 2.728

3.  Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.

Authors:  Yong Feng Wang; Chang Qing Yang; Ying Xuan Chen; Ai Ping Cao; Xiao Feng Yu; Yang Yu; Zi Yan Zhang; Xi Zhong Shen; Fei Liu; Lan Zhong; Ying Xin Wang; Zhan Ju Liu; Yan Hong Shi; Jie Zhong; Jing Nan Li; Yu Lan; Rhianna K Lenham; Andrew D Woodcock; Peter W Dettmar; Jing-Yuan Fang
Journal:  J Dig Dis       Date:  2019-06       Impact factor: 2.325

4.  Identification of Unique Transcriptomic Signatures and Hub Genes Through RNA Sequencing and Integrated WGCNA and PPI Network Analysis in Nonerosive Reflux Disease.

Authors:  Ye Zhao; Teng Ma; Duowu Zou
Journal:  J Inflamm Res       Date:  2021-11-23

Review 5.  Drugs for improving esophageal mucosa defense: where are we now and where are we going?

Authors:  Edoardo Savarino; Patrizia Zentilin; Elisa Marabotto; Gaia Pellegatta; Claudia Coppo; Matteo Brunacci; Pietro Dulbecco; Vincenzo Savarino
Journal:  Ann Gastroenterol       Date:  2017-08-17

6.  Gastroesophageal reflux symptoms among Italian university students: epidemiology and dietary correlates using automatically recorded transactions.

Authors:  Irene Martinucci; Michela Natilli; Valentina Lorenzoni; Luca Pappalardo; Anna Monreale; Giuseppe Turchetti; Dino Pedreschi; Santino Marchi; Roberto Barale; Nicola de Bortoli
Journal:  BMC Gastroenterol       Date:  2018-07-17       Impact factor: 3.067

Review 7.  Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders.

Authors:  Nicola de Bortoli; Salvatore Tolone; Marzio Frazzoni; Irene Martinucci; Giulia Sgherri; Eleonora Albano; Linda Ceccarelli; Cristina Stasi; Massimo Bellini; Vincenzo Savarino; Edoardo V Savarino; Santino Marchi
Journal:  Ann Gastroenterol       Date:  2018-09-26

8.  Weak acids induce PGE2 production in human oesophageal cells: novel mechanisms underlying GERD symptoms.

Authors:  Daichi Sadatomi; Toru Kono; Sachiko Mogami; Naoki Fujitsuka
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.